Home  >  News
Eppen_Centrifuge_Sept2026
you can get e-magazine links on WhatsApp. Click here
News
  Lupin launches Formoflo-G MDI, fixed-dose triple combination for COPD management,   October 07, 2026
  Glenmark Therapeutics launches pump packs for Adapalene gel USP,   October 06, 2026
  Zydus Lifesciences, MSN partner to launch first generic of Adempas in US,   October 06, 2026
  Acrotech Biopharma launches Adquey in US,   October 01, 2026
  Cytrellis Biosystems partners with KoreAx Company for commercialization of ellacor micro-coring technology in South Korea,   October 01, 2026
  Knight Therapeutics inks distribution agreement with Kyowa Kirin International for Poteligeo,   September 30, 2026
  Organon Canada announces approval and availability of Nduvra to treat moderate to severe atopic dermatitis in adult and paediatric patients 2 years of age and older,   September 29, 2026
  DKSH and Grünenthal ink new partnership agreement to accelerate access to innovative pain management solutions across eight markets in Asia-Pacific,   September 29, 2026
  Sun Pharma and LIB Therapeutics announce global licensing agreement for lerodalcibep,   September 28, 2026
  8th Annual Pharma Manufacturing & Automation Convention 2026 to be held in October 27th – 28th, 2026 at Hyderabad,   September 28, 2026
  US FDA Advisory Committee recommends marketing approval of GRAIL’s Galleri multi-cancer early detection test,   September 25, 2026
  UK MHRA grants marketing approval to Pharma Mar’s lurbinectedin for adults with extensive-stage small cell lung cancer,   September 25, 2026
  Bayer introduces mono-material PP blister for Talcid in Germany,   September 24, 2026
  Specialised Therapeutics expands partnership with Incyte to commercialise, distribute and register ruxolitinib cream in Australia,   September 22, 2026
  EMA committee recommends marketing approval for Novartis Cosentyx in polymyalgia rheumatica,   September 21, 2026
  Flow Neuroscience launches FL-100 in US; first US FDA-approved at-home tDCS treatment for depression,   September 19, 2026
  Takeda and Dr Reddy’s Laboratories enter into collaboration to promote and distribute Qdenga,   September 18, 2026
  Lundbeck receives marketing authorization for Vyepti in Japan for prevention of migraine attacks,   September 18, 2026
  Alkem launches NeuCeno for the treatment of partial-onset seizures in adult patients,   September 16, 2026
  Shilpa Biologicals and SPIMACO Bio Sign Strategic license agreement for PD-1 Biosimilar for MENA Market,   September 16, 2026

 Back
 
NPME-2026
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram